Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001104659-25-049536·Disc Medicine, Inc.
Schedule 13G ownership disclosure
Disc Medicine Inc
Common Stock, $0.0001 par value per share · CUSIP: 254604101
Event date: 2025-03-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Paradigm BioCapital Advisors LP
Shares: 1,210,971.00 · Class: 3.5%
- Paradigm BioCapital Advisors GP LLC
Shares: 1,210,971.00 · Class: 3.5%
- Senai Asefaw, M.D.
Shares: 1,210,971.00 · Class: 3.5%
- Paradigm BioCapital International Fund Ltd.
Shares: 1,069,143.00 · Class: 3.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-049536
- Form type
- SCHEDULE 13G/A
- Filer
- Disc Medicine, Inc.
- CIK
- CIK 1816736
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership